AnalystsMatthew WestonMatthew Weston's Stock Forecasts
AnalystsMatthew Weston
Analyst Ranking
Bottom 44%
#3129 out of 5510 analysts
Average Return
+8.43%
Win Rate
50%1 out of 2
Risk vs Reward
Poor
Good
Matthew Weston's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Astrazeneca PLCAZN | +38.05% | $148.90 | $205.55 | 2025-02-13 - 2026-02-13 | Strong Buy |
Matthew Weston Analyst Color
Get additional color on Matthew Weston's coverage of popular stocks
Matthew Weston's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
SanofiSNY | 1 | Hold | N/A | N/A | Downgrades | 8 months ago |
Dropbox IncDBX | 1 | Strong Sell | $27.00 | -27.63% | Assumes | a year ago |
Novo Nordisk A SNVO | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Astrazeneca PLCAZN | 2 | Strong Buy | N/A | N/A | Upgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.